Impact of hematological markers in prediction of severity of cutaneous drug eruptions
Journal of Pakistan Association of Dermatologists · 02.07.2023 · 33 (2) · 574-578
DOI: 10.66344/jpad.v33i2.2176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pakistan Association of Dermatologists, online erschienen am 02.07.2023. Verfasst von Rezvan Amiri und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Recognition of parameters to predict severity of drug eruptions can be helpful in early intervention in severe cases. In this study, we evaluate the role of hematological factors including neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte (PLR) ratio in prediction of severity in cutaneous drug reactions.
Methods
This is a retrospective cross-sectional study on 46 hospitalized patients with drug eruptions and 46 healthy individuals as control group. NLR/PLR was compared between patients with drug eruptions and healthy control group by independent t test. Moreover, the values of these hematological markers were compared between serious and non-serious types of drug eruptions by independent t test.
Results
Serious drug eruptions constitute nearly one-fourth of total drug eruptions. The mean values of NLR in case and control groups were 3.91±2.87 and 2.30±1.62, respectively (P=0.001). The mean values of PLR in case and control groups were 155.35±90.60 and 125±45.64, respectively (P=0.045). Females with drug eruptions had significantly higher PLR compared to males (P=0.02). Furthermore, there was no significant correlation between NLR/PLR in serious and non-serious types of drug reactions.
Conclusion
NLR/PLR was significantly higher in patients with drug eruptions compared to control group. There was no significant correlation between NLR/PLR with either demographic features of patients or severity of drug eruption; except significantly higher PLR in female with drug eruptions compared to males.
Zitieren
APA
Amiri, R., Iranmanesh, B., Amiri, M., Mohammadi, S., Khalili, M., & Aflatoonian, M. (2023). Impact of hematological markers in prediction of severity of cutaneous drug eruptions. Journal of Pakistan Association of Dermatologists, 33(2), 574-578. https://doi.org/10.66344/jpad.v33i2.2176
Vancouver
Amiri R, Iranmanesh B, Amiri M, Mohammadi S, Khalili M, Aflatoonian M. Impact of hematological markers in prediction of severity of cutaneous drug eruptions. Journal of Pakistan Association of Dermatologists. 2023;33(2):574-578. doi:10.66344/jpad.v33i2.2176
BibTeX
@article{Amiri2023,
author = {Amiri, Rezvan and Iranmanesh, Behzad and Amiri, Mina and Mohammadi, Saman and Khalili, Maryam and Aflatoonian, Mahin},
title = {Impact of hematological markers in prediction of severity of cutaneous drug eruptions},
journal = {Journal of Pakistan Association of Dermatologists},
year = {2023},
volume = {33},
number = {2},
pages = {574--578},
doi = {10.66344/jpad.v33i2.2176}
}
EUVIMED